Search

A group of European entrepreneurs and academics meet to compare notes on the problems of patenting in a global marketplace.

In a WSJ Europe article, two members of the Science|Business innovation board, J. Frank Brown and Jean-Philippe Courtois, discuss the way forward for Europe.

Cynics say it merely wants to curry favour with the European Union, but Intel’s revamp of its labs is a convincing model for corporate engagement in R&D, writes Nuala Moran.

European academia could lose as much as it might gain from the creation of the European Institute for Innovation and Technology, says Chalmers’ Karin Markides.

It's as good as official. Spreading R&D investment thinly across Europe makes no economic sense, according to a report by the European Investment Bank.

India's Council of Scientific and Industrial Research and the EPO have made a deal allowing the EPO to access India's Traditional Knowledge Digital Library.

The first third-generation biorefinery demonstration plant in the world has been commissioned in Finland. The plant is the first to process cellulose from crop waste.

With investment in listed companies down by 98 per cent – and still falling – France's biotech trade association is asking for help.

Agilent Technologies has sponsored a biology mass spectrometry facility at the National University of Ireland, Galway.

Everyone’s strapped for cash – except pharma. But the latest spending spree is no more of a fix for expiring patents than botox is for ageing skin, writes Nuala Moran.